Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0157212 CDK MODULATORS AND METHODS FOR THE TREATMENT OF CANCER
Disclosed is a polypeptide that includes amino acids 183-222 of CRIF, wherein the polypeptide does not include the full length CRIF1 amino acid sequence. Also...
2017/0157211 TREFOIL FAMILY FACTOR PROTEINS AND USES THEREOF
The invention provides for methods for treating an inflammatory disease of the digestive system in a subject by administering a trefoil family molecule. The...
2017/0157210 CAPCNA PEPTIDE THERAPEUTICS FOR CANCER
Administration of compositions comprising cell-permeable cancer-specific proliferating cell nuclear antigen derived peptides and their variants reduces the...
2017/0157209 Prescription of Intravenous Medication for Blocking Heroin or Morphine Intoxication Path and Using Thereof
Disclosed are a prescription of intravenous medication for blocking a heroin or morphine intoxication path and its using. The prescription of intravenous...
2017/0157208 Use of a Neurofilament Peptide for Targeting Neural Stem Cells
The present invention shows that the isolated NFL-TBS.sub.40-63 peptide is highly specific for neural stem cells. It is therefore presented here for use in a...
2017/0157207 METHOD OF TREATING CONDITIONS OF THE EYE WITH AN ANTI-VEGF DARPIN
Disclosed herein are methods for the treatment of a patient having an exudative age-related macular degeneration and other conditions of the retina by...
2017/0157206 HIGH PURITY ORITAVANCIN AND METHOD OF PRODUCING SAME
Drug substance preparations of oritavancin having high purity are disclosed, along with pharmaceutical compositions comprising such oritavancin drug substance...
2017/0157205 TREATING LIVER DISEASES
This document provides methods and materials related to treating liver conditions. For example, the methods and materials relating to the use of cAMP...
2017/0157204 CYCLIC TETRAPEPTIDES AND THERAPEUTIC APPLICATIONS THEREOF
There are provided compounds of formula I: ##STR00001## wherein k, m, n, p, R, R', R'', R''', R.sup.3, R.sup.4, R.sup.7 and R.sup.8 are as defined in the...
2017/0157203 VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION
Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time...
2017/0157202 VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION
Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time...
2017/0157201 A PEPTIDE OR PROTEIN STABILIZING FORMULATION
The invention relates to the use of a mixture of tetraethyleneglycol and aminosugars such as glucosamine or galactosamine to protect peptides and proteins and...
2017/0157200 Low-Dose Stable Formulations of Linaclotide
The present invention relates to stable pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various...
2017/0157199 LYTIC-PEPTIDE-HER2/NEU (HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2) LIGAND CONJUGATES AND METHODS OF USE
The invention relates to conjugates that bind to Her2/neu, methods of using conjugates that bind to Her2/neu and methods of treating undesirable or aberrant...
2017/0157198 TFPI INHIBITORS AND METHODS OF USE
The invention provides peptides that bind Tissue Factor Pathway Inhibitor (TFPI), including TFPI-inhibitory peptides, and compositions thereof. The peptides...
2017/0157197 METHODS OF USING GM604 IN MODULATING ALS DISEASE BIOMARKERS LEADING TO PROGNOSIS AND THERAPEUTIC TREATMENT FOR...
Biomarkers are not as commonly used in ALS drug development as in the drug development process for oncology. Biomarkers are important component of the ALS drug...
2017/0157196 PEPTIDE FRAGMENTS FOR INDUCING SYNTHESIS OF EXTRACELLULAR MATRIX PROTEINS
Short biologically active tetrapeptides are disclosed that are comprised of the sequences GxxG and PxxP where G (glycine) and P (proline) are maintained and x...
2017/0157195 PLANT EXTRACT COMPOSITION FOR REDUCING TOPICAL FAT AND PROMOTING WEIGHT LOSS AS WELL AS APPLICATIONS THEREOF
Disclosed in the present invention is the composition for reducing local fat and body weight, and pharmaceuticals and use thereof. The composition contains...
2017/0157194 COMPOSITION OF PLANT EXTRACT AND ITS PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
Provided is a plant extract composition and a pharmaceutical composition thereof for reducing body weight and body fat, wherein the plant extract composition...
2017/0157193 PLANT EXTRACT COMPOSITION FOR REDUCING TOPICAL FAT AND PROMOTING WEIGHT LOSS AS WELL AS APPLICATION THEREOF
Provided is a composition and a pharmaceutical composition for reducing topical fat or promoting weight loss, wherein the composition comprises a plant extract...
2017/0157192 USE OF THE CHINESE MEDICINE COMPOSITION AND DIANXIANNING IN THE PREPARATION OF A MEDICAMENT FOR PREVENTING OR...
Disclosed is a use of the Chinese medicine composition and Dianxianning in the preparation of a medicament for preventing or treating Alzheimer's disease. As...
2017/0157191 METHODS FOR ADDRESSING PHYSIOLOGICAL STRESSES AND AGING
Therapeutic compositions for addressing physiological stresses and aging include an immune modulator and one or more adaptogenic nutrients. Some non-limiting...
2017/0157190 ANTIVIRAL COMPOSITIONS AND METHODS
In general, embodiments of the present invention provide antiviral essential oil compositions, and methods of making and using the same. Essential oil...
2017/0157189 Medicinal Composition of Amaranth Extract Origin Having Enriched Nitrate Content and a Method of Preparing the same
An extract of Amaranth, having enriched nitrate content, L-arginine, Flavonoids, saponins, alkaloids, carbohydrates, proteins, potassium, and with negligible...
2017/0157188 ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS
The present invention provides an oncolytic virus comprising nucleotide sequence(s) encoding one or more immune checkpoint modulator(s). It also concerns a...
2017/0157187 REPLICATION-COMPETENT VESICULAR STOMATITIS VIRUSES
This document provides methods and materials related to vesicular stomatitis viruses. For example, replication-competent vesicular stomatitis viruses, nucleic...
2017/0157186 PHAGE TO TREAT BACTERIA ON SKIN
Methods and compositions having phage to prevent, inhibit or treat bacterial infection, e.g., on the dermis, are provided.
2017/0157185 PROBIOTIC DERIVED NON-VIABLE MATERIAL FOR INFECTION PREVENTION AND TREATMENT
A composition comprising a culture supernatant from a late-exponential growth phase of a batch-cultivation process for a probiotic such as LGG, for use in the...
2017/0157184 THERMO-STABLE STRAINS, PRODUCTS AND METHODS THEREOF
The present disclosure relates to thermo-stable/heat stable strain(s) of micro-organisms, obtaining such thermo-stable strains and incorporating them into food...
2017/0157183 Novel lactic acid bacteria and use thereof
The present invention discloses novel lactic acid bacteria, which are isolated Lactococcus lactis subsp. lactis LL358 and isolated Lactobacillus salivarius...
2017/0157182 COMPOSITIONS COMPRISING UNSATURATED FATTY ACIDS AND NITRIC OXIDE RELEASING COMPOUNDS AND USE THEREOF FOR...
Compositions include one or more unsaturated fatty acids and one or more nitric oxide releasing compounds. Methods for using such compositions can enhance...
2017/0157181 METHODS OF GENERATING, REPAIRING AND/OR MAINTAINING CONNECTIVE TISSUE IN VIVO
This invention relates to a method for generating, repairing and/or maintaining connective tissue in a subject. In one embodiment, the invention relates to a...
2017/0157180 PROGENITOR CELLS FROM WHARTON'S JELLY OF HUMAN UMBILICAL CORD
Human progenitor cells are extracted from perivascular tissue of human umbilical cord. The progenitor cell population proliferates rapidly, and harbours...
2017/0157179 TREATMENT OF RETINAL DEGENERATION USING PROGENITOR CELLS
Methods and compositions for treating and reducing retinal degeneration using progenitor cells and conditioned media from progenitor cells, such as...
2017/0157178 Cellular Compositions Used To Restore Stem Cell or Progenitor Cell Function and Methods Related Thereto
This disclosure relates to compounds, compositions and methods of epigenetically transforming cells. In certain embodiments, the disclosure relates to methods...
2017/0157177 Nutritional Composition for Improving Muscle Function and Daily Activity
The invention relates to a nutritional composition comprising (a) at least 18 en % of proteinaceous matter, said proteinaceous matter comprising whey; (b) at...
2017/0157176 Smart CAR Devices and DE CAR Polypeptides for Treating Disease and Methods for Enhancing Immune Responses
In an aspect, the present invention relates generally to the field of treating disease with CAR devices, Smart CAR devices, DE CAR devices, and/or Smart-DE CAR...
2017/0157175 FOAM CONTAINING BENZOYL PEROXIDE
The present invention relates to foamable compositions for treating acne comprising benzoyl peroxide; to a therapeutic kit comprising such compositions; and to...
2017/0157174 TREATMENT OF RETROVIRAL RESERVOIRS EXPLOITING OXIDATIVE STRESS
Activation of HIV-1 replication causes oxidative stress, which in turn potentiates HIV-1 replication. The common basis for the compounds of the present...
2017/0157173 BIOCOMPATIBLE COLLOIDAL SOLUTION OF GOLD NANOPARTICLES IN NON-AQUEOUS POLAR SOLVENT AND METHOD OF OBTAINING THEREOF
The present application relates to colloidal chemistry, specifically to methods of synthesising gold nanoparticle colloids in a non-aqueous solvent,...
2017/0157172 DIALYSIS PRECURSOR COMPOSITION
The present invention concerns a dialysis acid precursor composition for use during preparation of a dialysis acid concentrate solution and for mixing with...
2017/0157171 SURFACE-REACTED CALCIUM CARBONATE FOR DESENSITIZING TEETH
The present invention relates to surface-reacted calcium carbonate, wherein the surface-reacted calcium carbonate is a reaction product of natural or synthetic...
2017/0157170 COMPOSITIONS CONTAINING POLYMERIC SULFUR AND USES THEREOF
This invention relates to personal care compositions and methods of treating topical skin conditions using compositions containing polymeric sulfur S.sub.n....
2017/0157169 STRONTIUM BASED COMPOSITIONS AND FORMULATIONS FOR PAIN, PRURITUS, AND INFLAMMATION
Therapeutically-active compositions and formulations for treating pain, pruritus, irritation, inflammation, and tissue damage due to the irritation and...
2017/0157168 PREVENTION OF GASTRIC ULCER BY CARBON MONOXIDE
The invention relates to the use of carbon monoxide (CO) to inhibit the gastrointestinal side effects caused by non-steroidal anti-inflammatory drugs (NSAIDs)...
2017/0157167 PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES USING SYSTEMS AND METHODS FOR TRANSDERMAL NITRIC OXIDE DELIVERY
The present invention generally relates to compositions and methods for treatment of subjects having or at risk of arteriosclerosis, hypertension, sickle-cell...
2017/0157166 SOLID COMPOSITION
A solid composition comprising the following components (A) and (B): (A) from 20 to 55 mass % of a fat globule membrane component; and (B) from 0.2 to 4 mass %...
2017/0157165 APTAMER FOR FGF2 AND USE THEREOF
Provided by the present invention are an aptamer having an inhibitory activity on FGF2; a complex containing an aptamer having a binding activity or an...
2017/0157164 METHOD FOR REDUCING WHITE MATTER LESIONS, WHITE MATTER HYPERINTENSITIES (WMH), LEUKOARAIOSIS OR PERIVENTRICULAR...
The invention pertains to the use of one or more of uridine and cytidine, or salts, phosphates, acyl derivatives or esters thereof in the manufacture of a...
2017/0157163 METHOD FOR TREATING, STABILIZING OR SLOWING DOWN BRAIN GLUCOSE METABOLISM DEFICIT
The invention pertains to the use of (i) one or more of uridine and cytidine, or salts, phosphates, acyl derivatives or esters thereof, and (ii) a lipid...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.